[1]田琳,毕胜男,陈梦竹,等.基于网络药理学探索血府逐瘀汤治疗非小细胞肺癌的作用机制[J].西部中医药,2022,35(01):21-28.[doi:10.12174/j.issn.2096-9600.2022.01.05]
 TIAN Lin,BI Shengnan,CHEN Mengzhu,et al.Research on the Mechanism of Xuefu Zhuyu Decoction in the Treatment of NSCLC Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2022,35(01):21-28.[doi:10.12174/j.issn.2096-9600.2022.01.05]
点击复制

基于网络药理学探索血府逐瘀汤治疗非小细胞肺癌的作用机制
分享到:

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年01期
页码:
21-28
栏目:
药理研究
出版日期:
2022-01-15

文章信息/Info

Title:
Research on the Mechanism of Xuefu Zhuyu Decoction in the Treatment of NSCLC Based on Network Pharmacology
作者:
田琳 毕胜男 陈梦竹 牛崇阳 齐文龙 王檀
长春中医药大学附属医院,吉林 长春 130021
Author(s):
TIAN Lin BI Shengnan CHEN Mengzhu NIU Chongyang QI Wenlong WANG Tan
Affiliated Hospital of Changchun University of Chinese Medicine, Changchun 130021, China
关键词:
非小细胞肺癌血府逐瘀汤作用机制网络药理学
Keywords:
NSCLCdecoctionmechanismnetwork pharmacology
分类号:
R734
DOI:
10.12174/j.issn.2096-9600.2022.01.05
摘要:
目的运用中药复方网络药理学和基因芯片探讨血府逐瘀汤治疗非小细胞肺癌(non-small-cell lung carcinoma,NSCLC)的作用机制。 方法利用基因表达数据库(gene expression omnibus,GEO)查找NSCLC的基因芯片,下载NSCLS患者和正常人组织基因并进行差异分析;通过中药系统药理学分析平台(traditional Chinese medicine systems pharmacology database and analysis platform,TCMSP)搜索血府逐瘀汤的活性成分和药物靶点;运用Cytoscape v3.6.0软件,以血府逐瘀汤和NSCLC的交集基因与化合物作为输入数据,构建血府逐瘀汤的中药复方调控网络;利用Cytoscape v3.6.0软件,从深度数据包检测数据库(deep packet inspection,DPI)、蛋白相互作用数据库(biological general repository for interaction datasets,BIOGRID)、人类蛋白参考数据库(human protein reference database,HPRD)等数据库中构建蛋白互作网络(protein-protein interaction networks,PPI);运用R语言进行基因本体(gene ontology,GO)及京都基因与基因组百科全书(kyoto encyclopedia of genes and genomes,KEGG)通路富集分析。 结果从GEO数据库中获取NSCLC与正常组织的差异基因2861个,上调基因1313个,下调基因1548个;获得血府逐瘀汤与NSCLC交集基因69个,候选化合物82个;GO富集分析获得血府逐瘀汤的药物活性成分主要富集在对活性氧的反应过程、营养代谢过程、类固醇激素代谢过程等;血府逐瘀汤治疗NSCLC主要富集在膀胱癌信号通路、糖尿病并发症中的AGE-RAGE信号通路、肿瘤坏死因子信号通路等。 结论网络药理学可以通过建立化学成分、靶点、疾病数据库分析血府逐瘀汤治疗NSCLC的作用机制,为临床使用血府逐瘀汤提供数据支持。
Abstract:
ObjectiveTo discuss the mechanism of Xuefu Zhuyu decoction in treating NSCLC using network pharmacology of herbal compounds and gene chip. MethodsGEO database was used to search gene chips of NSCLC, download tissue genes of NSCLC patients and normal person and analyze the differences; TCMSP was used to analyze the active ingredients and drug targets of Xuefu Zhuyu decoction; software Cytoscape v3.6.0 was utilized to construct TCM compound regulation network of Xuefu Zhuyu decoction by taking the intersection genes and compounds of Xuefu Zhuyu decoction and NSCLC as input data; software Cytoscape v3.6.0 was applied to structure PPI protein protein interaction network from DPI, BIOGRID and HPRD databases; R language was used to perform GO and KEGG pathway enrichment analysis. ResultsAll 2861 differential genes between NSCLC and normal tissues were obtained from GEO database, 1313 up-regulated genes and 1548 down-regulated genes; 69 intersection genes between Xuefu Zhuyu decoction and NSCLC, and 82 candidate compounds were obtained; GO enrichment analysis showed that the active ingredients of Xuefu Zhuyu decoction were mainly concentrated in the reaction process to reactive oxygen species, nutritional metabolism and steroid hormone metabolism; Xuefu Zhuyu decoction in the treatment of NSCLC were mainly concentrated in AGE-RAGE signaling pathway and tumor necrosis factor signaling pathway in bladder cancer signaling pathway and diabetic complications. ConclusionNetwork pharmacology could be used to analyze the mechanism of Xuefu Zhuyu decoction in the treatment of NSCLC via chemical ingredients, targets, disease databases, and provide data support for clinical use of Xuefu Zhuyu decoction.

相似文献/References:

[1]宋春燕,王翠英.参芎葡萄糖联合放疗治疗局部晚期非小细胞肺癌50例临床观察[J].西部中医药,2013,26(01):89.
 SONG Chunyan,WANG Cuiying.Clinical Observation on ShenXiong Glucose Combined with Radiotherapy for 50 Cases of Local Non-small-cell Lung Cancer at Advanced Stage[J].Western Journal of Traditional Chinese Medicine,2013,26(01):89.
[2]张红林.血府逐瘀汤异病同治临证应用举隅[J].西部中医药,2013,26(05):84.
 ZHANG Honglin.Examples of Clinical Application of XueFu ZhuYuTangto the Same Therapy for Different Diseases[J].Western Journal of Traditional Chinese Medicine,2013,26(01):84.
[3]张霞,杨红霞.针灸配合中药治疗偏头痛60例[J].西部中医药,2013,26(06):101.
 ZHANG Xia,YANG Hongxia.Acupuncture and Herbs in Treating 60 Cases of Migraine[J].Western Journal of Traditional Chinese Medicine,2013,26(01):101.
[4]魏海东,王晓平,万毅新,等.康艾注射液联合NP方案治疗非小细胞肺癌50例疗效观察[J].西部中医药,2012,25(09):57.
 WEI Hai-dong,WANG Xiao-ping,WAN Yi-xin,et al.Kang′ai Injection and NP Therapy in the Treatment for 50 Cases of Non-Small-Cell Lung Cancer[J].Western Journal of Traditional Chinese Medicine,2012,25(01):57.
[5]张会仲.中西医结合治疗冠心病心绞痛45例[J].西部中医药,2014,27(04):104.
 ZHANG Huizhong.Treatment for 45 Patients Suffering from Coronary Heart Disease Angina Pectoris by Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2014,27(01):104.
[6]席彩霞,杨国泉,苏安平,等.贞芪益气胶囊联合 GP 方案治疗晚期非小细胞肺癌的临床研究[J].西部中医药,2014,27(09):4.
[7]廖绛阳,张红△.血府逐瘀汤加味配合γ-刀治疗气虚血瘀证中晚期非小细胞肺癌30例[J].西部中医药,2015,28(10):98.
[8]杜自忠,王晨,张明星,等.介入联合血府逐瘀汤治疗急性肺动脉栓塞30例[J].西部中医药,2015,28(10):104.
[9]魏平,席恒.血府逐瘀汤加减治疗偏头痛40例[J].西部中医药,2015,28(12):89.
[10]李洁,张波,安贺军,等.血府逐瘀汤对冠心病患者红外热图胸部低温区的影响[J].西部中医药,2018,31(01):4.
 LI Jie,ZHANG Bo,AN Hejun,et al.Influence of XueFu ZhuYu Decoction on Chest Low Temperature Zone of the Patients with Coronary Heart Disease by Infrared Thermography[J].Western Journal of Traditional Chinese Medicine,2018,31(01):4.

备注/Memo

备注/Memo:
田琳(1980—),女,硕士学位,主任医师。研究方向:呼吸疾病的中医防治。
更新日期/Last Update: 2022-01-15